Skip to main content
. 2020 Mar 26;21:75. doi: 10.1186/s12931-020-01339-7

Table 1.

Demographic and baseline characteristics

Placebo
(N = 3)		 GSK3008348 1000 mcg
(N = 5)
Age (years), mean (SD) 70.3 (3.1) 73.6 (2.3)
Males, n (%) 3 (100) 4 (80)
BMI (kg/m2), mean (SD) 31.4 (1.1) 27.9 (1.9)
Race, n (%)
White/Caucasian/European heritage 3 (100) 5 (100)
Lung function

FVC percent predicted (%), median (range)

FEV1 percent predicted (%), median (range)

DLCO percent predicted (%), median (range)

92.6 (77.9–93.6)

90.0 (89.8–99.2)

43.3 (43.0–50.1)

91.0 (78.5–113.4)

99.0 (71.4–123.9)

48.0 (41.7–53.5)

BMI body mass index